Completed NA INTERVENTIONAL 2-arm NCT00666068

Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism

Effects of CRH on the Sleep in Patients With Hypopituitarism

Sponsor: Max-Planck-Institute of Psychiatry

Interventions Placebo corticotropin releasing hormone (CRH)

Updated 5 times since 2017 Last updated: May 11, 2011 Started: Feb 29, 2008 Primary completion: Oct 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00666068, this NA trial focuses on Hypopituitarism and remains completed. Sponsored by Max-Planck-Institute of Psychiatry, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Max-Planck-Institute of Psychiatry

Data source: Max-Planck-Institute of Psychiatry

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany